Search
Close this search box.

Cost, Quality Debates Dominate Cancer Policy Workshop

How do we go about ”Ensuring Patient Access to Cancer Drugs”? Ethicists, economists, physicians and academics gathered for the Institute of Medicine’s National Cancer Policy Forum Workshop this week to discuss the topic.

High Co-Pays Inhibit Access for Cancer Patients

You can’t put a price on health, the saying goes. But for certain leukemia patients who need protein kinase inhibitor treatment, cost can prove to be not only a key factor but also a barrier to wellness.